Jump Financial’s Tango Therapeutics TNGX Stock Holding History

Jump Financial’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	+37,379	New	+$924K	0.01%	1109
2024 Q2	–	Sell	-21,494	Closed	-$171K	–	2266
2024 Q1	$171K	Buy	+21,494	New	+$230K	﹤0.01%	1723
2023 Q2	–	Sell	-12,518	Closed	-$49.4K	–	2161
2023 Q1	$49.4K	Sell	12,518 -5,533	-31%	-$32.1K	﹤0.01%	1497
2022 Q4	$131K	Buy	18,051 +4,511	+33%	+$31.7K	0.01%	1383
2022 Q3	$49K	Buy	+13,540	New	+$57.8K	﹤0.01%	1498

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jump Financial's TNGX Position: Q2 2026 in Review

Jump Financial opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 37,379 shares worth $1.17M. The stake represents 0.01% of the portfolio and ranks #1109 among its holdings. This is a return to the name: Jump Financial previously reported a position in TNGX as recently as Q1 2024.

Jump Financial first reported a position in TNGX in Q3 2022 and has held it in 5 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Jump Financial held 37,379 shares of Tango Therapeutics worth $1.17M as of Q2 2026.
Tango Therapeutics was a new Jump Financial position in Q2 2026.
Tango Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1109 holding.
Jump Financial first reported a position in Tango Therapeutics in Q3 2022 and has held it in 5 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.